CGEM Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year 9 hours ago Cullinan Therapeutics posts $0.73 per share loss in Q4 2025, matching year-ago results as the pre-revenue biotech maintains clinical development… Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings 9 hours ago **Cullinan Therapeutics Inc Reports Q4 2025 Results**